5α‐Reductase inhibitors and prostatic disease

This publication has 59 references indexed in Scilit:

• Critical Developmental Periods for Effects on Male Rat Genitalia Induced by Finasteride, a 5α-Reductase Inhibitor
  Toxicology and Applied Pharmacology, 1993
• The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia
  The Prostate, 1993
• The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia
  The Prostate, 1993
• 17β-acylurea derivatives of 4-azasteroids as inhibitors of testosterone 5α-reductase
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• Reduction of testosterone availability to 5α-reductase by human sex hormone-binding globulin in the rat ventral prostate gland in vivo
  The Prostate, 1990
• Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia
  Neurourology and Urodynamics, 1989
• Sexual Differentiation of the Gonads and of the Reproductive Tract
  Neonatology, 1989
• The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1987
• Biochemical and biological studies with 4-aza-steroidal 5α-reductase inhibitors
  Journal of Steroid Biochemistry, 1983